Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient‐derived primary prostate cells

BACKGROUND: Drug repurposing enables the discovery of potential cancer treatments using publically available data from over 4000 published Food and Drug Administration approved and experimental drugs. However, the ability to effectively evaluate the drug's efficacy remains a challenge. Impedime...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Prostate
Autors principals: Naeem, Aisha, Dakshanamurthy, Sivanesan, Walthieu, Henry, Parasido, Erika, Avantaggiati, Maria, Tricoli, Lucas, Kumar, Deepak, Lee, Richard J., Feldman, Adam, Noon, Muhammad S., Byers, Stephen, Rodriguez, Olga, Albanese, Chris
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7540414/
https://ncbi.nlm.nih.gov/pubmed/32761925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.24050
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars